Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2025-12-26 @ 1:41 PM
Study NCT ID:
NCT01076959
Status:
COMPLETED
Last Update Posted:
2012-08-28
First Post:
2010-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis
Sponsor:
Abbott
Organization:
Study Overview
Official Title:
Humira 40 mg/0.8 mL for Subcutaneous Injection - Drug Use Investigation (All Patient Investigation) for Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To clarify the following matters:
* Unknown adverse reactions (especially clinically significant adverse reactions)
* Incidence and conditions of occurrence of adverse reactions in the clinical setting
* Factors that may affect the safety and effectiveness of Humira
* Unknown adverse reactions (especially clinically significant adverse reactions)
* Incidence and conditions of occurrence of adverse reactions in the clinical setting
* Factors that may affect the safety and effectiveness of Humira
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: